Effect of LY2216684 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects
Latest Information Update: 08 Nov 2021
Price :
$35 *
At a glance
- Drugs Edivoxetine (Primary) ; Warfarin
- Indications Major depressive disorder
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 11 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Feb 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.